Mauro Mansutti

Neoadjuvant and adjuvant trastuzumab in patients with HER2-positive locally advanced breast cancer (NOAH): follow-up of a randomised controlled superiority trial with a parallel HER2-negative cohort

Luca Gianni, W. Eiermann, Aňa Lluch et al. · The Lancet Oncology · 2014 · 491 citations

Medicine, Oncology, Breast Oncology +16

Measures of Outcome in Metastatic Breast Cancer: Insights From a Real-World Scenario

Marta Bonotto, Lorenzo Gerratana, Elena Poletto et al. · The Oncologist · 2014 · 289 citations · Full text

Medicine, Biostatistics, Oncology +17

Phase III Trial Evaluating the Addition of Paclitaxel to Doxorubicin Followed by Cyclophosphamide, Methotrexate, and Fluorouracil, As Adjuvant or Primary Systemic Therapy: European Cooperative Trial in Operable Breast Cancer

Luca Gianni, José Baselga, W. Eiermann et al. · Journal of Clinical Oncology · 2009 · 216 citations · Full text

Medicine, Oncology, Pharmacology +17

Taxane-induced nail changes: incidence, clinical presentationand outcome

Alessandro Marco Minisini, Antonellá Tosti, Alberto Sobrero et al. · Annals of Oncology · 2003 · 169 citations · Full text

Medicine, Dermatology, Oncology +12

Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy

Luca Gianni, José Baselga, W. Eiermann et al. · Clinical Cancer Research · 2005 · 165 citations

Medicine, Oncology, Pharmacology +15